AIHC Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

AIHC Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2024	Orange Dental	$130.0M Series B	Oceanpine Capital, OrbiMed	3W Capital, Adjuvant Capital, Eight Roads Ventures, F-Prime Capital, Haitong International, Hillhouse Capital Group, MSA Capital, Superstring Capital
Mar 27, 2023	ArriVent Biopharma	$155.0M Series B	Elena Viboch, James Healy	Catalio Capital Management, HBM Healthcare Investments, Hongshan Capital Group (Sequoia Capital China), Infinitum Asset Management, Lilly Asia Ventures, Octagon Capital, Carl Gordon, Shanghai Healthcare Capital, Sirona Capital, Terra Magnum Capital Partners, Unicorn Capital, Zoo Capital
Mar 4, 2022	InxMed	$50.0M Series B	Hua Yi	Growth Fund, Hosencare Fund
Aug 17, 2021	Meditrust	$308.7M Series C	Boyu Capital, Janchor Partners	Bank of China Group Investment, China Everbright, China Renaissance, CICC Capital, Lake Bleu Capital, Lilly Asia Ventures, Marathon Venture Partners, New Alliance Capital, Shanghai Biopharmaceutical Fund, Sinovation Ventures
Jun 29, 2021	OnCusp Therapeutics	$25.0M Seed	Lynn Yang	Oriza Ventures
Feb 1, 2021	LakeShore Biopharma	$130.0M Series B	OrbiMed, Dave Chenn	3W Capital, Adjuvant Capital, Eight Roads Ventures, Epiphron Capital, F-Prime Capital, Haitong International, Hillhouse Capital, MSA Capital, Superstring Capital
Sep 1, 2020	InventisBio	$150.0M Series D	Hillhouse affiliate GL Ventures	Qiming Venture Partners, Advantech Capital, CMB International, Dyee Capital, Janchor Partners, Lilly Asia Ventures, Matrix Partners China, OrbiMed, Pudong Innotek
Nov 9, 2019	Akeso	$150.0M Series D	Loyal Valley Capital, Sino Biopharmaceutical	CDG International, Lake Bleu Capital, OrbiMed, Shenzhen Capital Group